SAN FRANCISCO, Nov. 7 – Paradigm Genetics on Wednesday posted third-quarter revenues of $6.3 million versus $3.5 for the same quarter a year ago, the company announced.

The Research Triangle Park, N.C.-based company attributed the revenue rise to output related to partnerships with Bayer and Monsanto.

Total operating expenses for the period increased 31 percent to $10.2 million from $7.8 million for the year-ago period.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.